A detailed history of Ferguson Shapiro LLC transactions in Biodesix Inc stock. As of the latest transaction made, Ferguson Shapiro LLC holds 10,000 shares of BDSX stock, worth $13,500. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$13,500
Previous $15,000 13.33%
% of portfolio
0.01%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$1.21 - $1.71 $12,100 - $17,100
10,000 New
10,000 $15,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $54M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Ferguson Shapiro LLC Portfolio

Follow Ferguson Shapiro LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Shapiro LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Shapiro LLC with notifications on news.